1. Home
  2. BIOX vs NRXP Comparison

BIOX vs NRXP Comparison

Compare BIOX & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioceres Crop Solutions Corp.

BIOX

Bioceres Crop Solutions Corp.

HOLD

Current Price

$0.41

Market Cap

61.5M

Sector

Industrials

ML Signal

HOLD

Logo NRX Pharmaceuticals Inc.

NRXP

NRX Pharmaceuticals Inc.

HOLD

Current Price

$2.09

Market Cap

54.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIOX
NRXP
Founded
2001
2015
Country
Argentina
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.5M
54.2M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BIOX
NRXP
Price
$0.41
$2.09
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$4.33
$34.00
AVG Volume (30 Days)
1.4M
782.2K
Earning Date
05-19-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$9,292.65
Revenue Next Year
$37.82
$376.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$1.58
52 Week High
$5.18
$3.84

Technical Indicators

Market Signals
Indicator
BIOX
NRXP
Relative Strength Index (RSI) 38.34 53.93
Support Level $0.37 $1.98
Resistance Level $0.68 $2.23
Average True Range (ATR) 0.05 0.17
MACD 0.01 0.05
Stochastic Oscillator 17.83 48.70

Price Performance

Historical Comparison
BIOX
NRXP

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Share on Social Networks: